DNM1 and cancer: Others have emphasized pathways related to synaptic vesicles and key neurotransmitters (i.e., dynamin-1) being influenced by cancer and cancer treatment, which may impact the onset and severity of CRCI (Nordhjem and Hjalgrim, 2025; Ng et al., 2025).